Source: Therma Bright.
  • Therma Bright (THRM) has announced a C$6M private placement with institutional investors
  • The company will use the proceeds for general working capital purposes
  • It expects the placement to close on or about February 18, 2022
  • Therma Bright is a medical diagnostic and device technology company
  • Therma Bright (THRM) is down by 16.67 per cent trading at $0.3125 per share

Therma Bright (THRM) has announced a C$6M private placement with institutional investors.

The company will issue 20M units priced at $0.30 comprised of one common share and one common share purchase warrant.

Each warrant entitles the holder to purchase one common share for $0.375 for five years following the issuance date.

The company will use the proceeds for general working capital purposes.

It expects the placement to close on or about February 18, 2022.

H.C. Wainwright & Co. is acting as the exclusive placement agent.

Therma Bright is a medical diagnostic and device technology company. It developed the AcuVid COVID-19 Rapid Antigen Saliva Test.

Therma Bright (THRM) is down by 16.67 per cent trading at $0.3125 per share as of 12:43 pm EST.

More From The Market Online

Serve Robotics expands autonomous Uber deliveries in Florida

Serve Robotics (NASDAQ:SERV), an autonomous delivery company spun out from Uber in 2021, is expanding its services into Fort Lauderdale.

Siemens Energy, Deutsche Bank, Almonty: Why 2025 belonged to the tankers – and 2026 will be the year of the speedboats

Siemens Energy, Deutsche Bank and Almonty Industries are leveraging technology growth, banking stability and rare tungsten production in 2026.

Take advantage of the panic: Why buy Rheinmetall, Almonty Industries and DroneShield now?

Rheinmetall, Almonty and DroneShield benefit from defense and critical-metal trends, offering growth despite volatility and governance risks.